ViiV Healthcare rolled out Backseat Hotseat, a campaign to normalize conversations about HIV prevention, with the help of ...

New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach ...

The government of Colombia, after signaling its intent to do so at the end of 2023, issued a compulsory license on April 24 for access to generic versions of HIV drug dolutegravir, without the ...

Federal agriculture and health officials have increased communication with the public in recent days about an outbreak of avian influenza in cows across multiple states.

SAN ANTONIO — HIV is no longer a death sentence for those who live with it, and new therapies with benefits lasting longer ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of ...

We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP ...

The U.S. Food and Drug Administration has approved Dovato (dolutegravir/lamivudine) for adolescents living with HIV. The ...

Colombia issues compulsory license for Viiv’s HIV drug Tivicay The government of Colombia, after signaling its intent to do so at the end of 2023, issued a compulsory license on April 24 for access to ...

GSK subsidiary ViiV Healthcare and Exavir Therapeutics have settled their dispute over licensing rights for HIV drug ...

Mumbai, India-based generic drugmaker Lupin Limited revealed that it has received tentative approval from Food and Drug Administration (FDA), under the US President’s Emergency Plan for AIDS Relief ...